Bank Of America Corp Blueprint Medicines Corp Transaction History

Bank Of America Corp

$1.21 Trillion
Q1 2025

A detailed history of Bank Of America Corp transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Bank Of America Corp holds 716,906 shares of BPMC stock, worth $92 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

716,906

Previous 395,031 81.48%

Holding current value

$92 Million

Previous $34.5 Million 84.17%

% of portfolio

0.01%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$86.69 - $115.63 $27.9 Million - $37.2 Million	321,875 Added 81.48%	716,906 $63.5 Million
Q4 2024 Feb 14, 2025	SELL	$82.48 - $101.39 $1.35 Million - $1.67 Million	-16,424 Reduced 3.99%	395,031 $34.5 Million
Q3 2024 Nov 14, 2024	BUY	$84.1 - $120.5 $652,531 - $934,959	7,759 Added 1.92%	411,455 $38 Million
Q2 2024 Aug 14, 2024	BUY	$85.18 - $108.78 $5.79 Million - $7.39 Million	67,921 Added 20.23%	403,696 $43.5 Million
Q1 2024 May 15, 2024	BUY	$73.17 - $99.79 $1.8 Million - $2.45 Million	24,559 Added 7.89%	335,775 $31.9 Million
Q4 2023 Feb 14, 2024	SELL	$43.96 - $92.84 $742,308 - $1.57 Million	-16,886 Reduced 5.15%	311,216 $28.7 Million
Q2 2023 Aug 14, 2023	SELL	$42.2 - $66.37 $3.58 Million - $5.64 Million	-84,921 Reduced 20.56%	328,102 $20.7 Million
Q1 2023 May 12, 2023	BUY	$37.97 - $50.0 $2.92 Million - $3.85 Million	76,942 Added 22.89%	413,023 $18.6 Million
Q4 2022 Feb 10, 2023	BUY	$41.06 - $66.48 $2.39 Million - $3.87 Million	58,227 Added 20.96%	336,081 $14.7 Million
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $3.66 Million - $5.69 Million	-73,240 Reduced 20.86%	277,854 $18.3 Million
Q2 2022 Aug 12, 2022	SELL	$45.23 - $70.15 $723,544 - $1.12 Million	-15,997 Reduced 4.36%	351,094 $17.7 Million
Q1 2022 May 16, 2022	BUY	$54.1 - $110.08 $4.41 Million - $8.97 Million	81,501 Added 28.54%	367,091 $23.5 Million
Q4 2021 Feb 08, 2022	BUY	$94.25 - $115.99 $2.3 Million - $2.84 Million	24,448 Added 9.36%	285,590 $30.6 Million
Q3 2021 Nov 15, 2021	BUY	$80.98 - $109.47 $209,333 - $282,979	2,585 Added 1.0%	261,142 $26.8 Million
Q2 2021 Sep 13, 2021	BUY	$82.78 - $101.0 $21.4 Million - $26.1 Million	258,557 New	258,557 $22.7 Million

Others Institutions Holding BPMC

# of Institutions

391

Shares Held

68.5M

Call Options Held

1.54M

Put Options Held

1.08M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $7.66B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Blueprint Medicines Corp Transaction History